The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...
MedPage Today on MSN20h
FTC Sues Top Pharmacy Benefit Managers Over Insulin PricesThe federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Washington Post on MSN23h
FTC sues pharmacy insurance managers, alleging unfair drug prices“This action continues a troubling pattern from the FTC of unsubstantiated and ideologically driven attacks on pharmacy benefit managers,” Andrea Nelson, Cigna’s chief legal officer, said in a ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The FTC said the rebating practices of the three companies ... as a big campaign topic during this year’s presidential ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin in order to reap ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback